Potential targets of natural medicines: preventing lung cancer pre-metastatic niche formation by regulating exosomes DOI Creative Commons
Xiaoyu Zhu, Jie Li

Frontiers in Oncology, Journal Year: 2023, Volume and Issue: 13

Published: Aug. 28, 2023

Lung cancer is one of the most devastating diseases worldwide with high incidence and mortality, continues to rise. Metastasis leading cause death in lung patients, yet molecular effectors underlying tumor dissemination remain poorly defined. Research findings recent years confirmed primed microenvironment future metastatic sites, called pre‐metastatic niche, a prerequisite for overt metastasis. Exosomes have recently emerged as important players niche formation. Natural medicines traditionally been rich sources drug discovery. Some them exhibit favorable anti-lung activity. The review focused on latest advances regulation formation by contents exosomes representative natural medicines. Additionally, mechanism was summarized detail, which would provide new insights anti-cancer development.

Language: Английский

Portrait of WWP1: the current state in human cancer DOI Creative Commons

Jiaming Lei,

Jun Chen,

Wenwen Yu

et al.

Frontiers in Cell and Developmental Biology, Journal Year: 2025, Volume and Issue: 12

Published: Jan. 30, 2025

WWP1, a member of the C2-WW-HECT E3 ligase family, is an ubiquitin-protein containing WW domains. This enzyme plays critical role in regulating diverse cellular processes. Its expression modulated by various factors and non-coding RNAs, resulting ubiquitination that affects substrate protein degradation. WWP1 demonstrates dual function, acting predominantly as oncogene tumors but occasionally tumor suppressor. review summarizes WWP1’s biological roles, therapeutic potential oncology, upstream regulatory factors, downstream substrates. It aims to promote research on antitumor effects, improve understanding its tumorigenesis, support development targeted therapies.

Language: Английский

Citations

0

Oxaliplatin-loaded natural killer cell-derived exosomes for a safe and efficient chemoimmunotherapy of colorectal cancer DOI
Han Yu, Weicheng Zheng,

Y. S. Zhang

et al.

Journal of Pharmaceutical Sciences, Journal Year: 2025, Volume and Issue: unknown, P. 103783 - 103783

Published: April 1, 2025

Language: Английский

Citations

0

Crosstalk between colorectal cancer cells and cancer-associated fibroblasts in the tumor microenvironment mediated by exosomal noncoding RNAs DOI Creative Commons

Shichen Sun,

Yanyu Zhang, Yubing Li

et al.

Frontiers in Immunology, Journal Year: 2023, Volume and Issue: 14

Published: May 10, 2023

Colorectal cancer (CRC) is a common malignant tumor of the digestive system, and its morbidity rates are increasing worldwide. Cancer-associated fibroblasts (CAFs), as part microenvironment (TME), not only closely linked to normal fibroblasts, but also can secrete variety substances (including exosomes) participate in regulation TME. Exosomes play key role intercellular communication by delivering intracellular signaling (e.g., proteins, nucleic acids, non-coding RNAs), an number studies have shown that RNAs exosomal origin from CAFs associated with formation CRC microenvironment, increase ability grow metastasis, mediate immunosuppression, involved mechanism drug resistance patients receiving. It after radiotherapy patients. In this paper, we review current status progress research on CAFs-derived CRC.

Language: Английский

Citations

7

A clinically relevant large‐scale biomanufacturing workflow to produce natural killer cells and natural killer cell‐derived extracellular vesicles for cancer immunotherapy DOI Creative Commons
Frédéric St-Denis Bissonnette, Sarah E. Cummings, Shirley Qiu

et al.

Journal of Extracellular Vesicles, Journal Year: 2023, Volume and Issue: 12(12)

Published: Dec. 1, 2023

Abstract Natural killer cell‐derived extracellular vesicles (NK‐EVs) have shown promising potential as biotherapeutics for cancer due to their unique attributes cytotoxic nanovesicles against cells and immune‐modulatory activity towards immune cells. However, a biomanufacturing workflow is needed produce clinical‐grade NK‐EVs pre‐clinical clinical applications. This study established novel using closed‐loop hollow‐fibre bioreactor continuously from the clinically relevant NK92‐MI cell line under serum‐free, Xeno‐free feeder‐free conditions following GMP‐compliant conditions. The NK92 grown in three continuous production lots resulted large quantities of both NK NK‐EV at end each lot (over 10 9 viable 13 EVs), while retaining payload (granzyme B perforin), pro‐inflammatory cytokine (interferon‐gamma) content cytotoxicity human leukemic K562 with limited off‐target toxicity healthy fibroblast scalable has facilitate translation adoptive cell‐based NK‐EV‐based immunotherapies GMP considerations.

Language: Английский

Citations

7

CRISPR-Cas-based biosensors for the detection of cancer biomarkers DOI

Yuxin Feng,

J. Yang,

Ziping He

et al.

Analytical Methods, Journal Year: 2024, Volume and Issue: 16(39), P. 6634 - 6653

Published: Jan. 1, 2024

Along with discovering cancer biomarkers, non-invasive detection methods have played a critical role in early diagnosis and prognostic improvement. Some traditional been used for detecting but they are time-consuming involve materials human costs. With great flexibility, sensitivity specificity, the clustered regularly interspaced short palindromic repeats (CRISPR)-associated system provides wide range of application prospects this field. Herein, we introduce background CRISPR-Cas (CRISPR-associated) comprehensively summarize strategies mediated by system, including four kinds biochemical-based markers: nucleic acid, enzyme, tumor-specific protein exosome. Furthermore, discuss challenges implementing clinical applications.

Language: Английский

Citations

1

Hypoxia exosome derived CEACAM5 promotes tumor‐associated macrophages M2 polarization to accelerate pancreatic neuroendocrine tumors metastasis via MMP9 DOI
Mujie Ye, Feiyu Lu, Danyang Gu

et al.

The FASEB Journal, Journal Year: 2024, Volume and Issue: 38(13)

Published: June 26, 2024

Abstract Exosomes play significant roles in the communications between tumor cells and microenvironment. However, specific mechanisms by which exosomes modulate development under hypoxia pancreatic neuroendocrine tumors (pNETs) are not well understood. This study aims to investigate these made several important discoveries. We found that hypoxic derived from pNETs can activate tumor‐associated macrophages (TAM) M2 phenotype, turn, M2‐polarized TAM, facilitate migration invasion of cells. Further investigation revealed CEACAM5, a protein highly expressed cells, is enriched cell‐derived exosomes. Hypoxic exosomal CEACAM5 was observed induce polarization TAM through activation MAPK signaling pathway. Coculturing with or treated enhanced metastatic capacity In conclusion, findings suggest generate CEACAM5‐rich microenvironment, turn polarize promote malignant Targeting could potentially serve as diagnostic therapeutic strategy for pNETs.

Language: Английский

Citations

1

The biological roles of exosome-encapsulated traditional Chinese medicine monomers in neuronal disorders DOI Creative Commons
Pang Chen, Jie Zhang,

Yujin Gu

et al.

Journal of Pharmaceutical Analysis, Journal Year: 2024, Volume and Issue: unknown, P. 101131 - 101131

Published: Oct. 1, 2024

Language: Английский

Citations

1

Large-scale Isolation of Exosomes Derived from NK Cells for Anti-tumor Therapy DOI

Heyong Luo,

Jing Zhang,

Anqing Yang

et al.

BIO-PROTOCOL, Journal Year: 2023, Volume and Issue: 13(11)

Published: Jan. 1, 2023

Exosomes are lipid bilayer-enclosed vesicles, actively secreted by cells, containing proteins, lipids, nucleic acids, and other substances with multiple biological functions after entering target cells. derived from NK cells have been shown to certain anti-tumor effects potential applications as chemotherapy drug carriers. These developments resulted in high demand for exosomes. Although there has large-scale industrial preparation of exosomes, they only generally engineered such HEK 293T. The specific cellular exosomes is still a major problem laboratory studies. Therefore, this study, we used tangential flow filtration (TFF) concentrate the culture supernatants isolated cell-derived (NK-Exo) ultracentrifugation. Through series characterization functional verification NK-Exo, characterization, phenotype, activity NK-Exo were verified. Our study provides considerably time- labor-saving protocol isolation NK-Exo.

Language: Английский

Citations

2

Circulating exosomes in sepsis: A potential role as diagnostic biomarkers, therapeutic and drug delivery carriers DOI Creative Commons
Roushka Bhagwan Valjee, Usri H. Ibrahim, Kwanele Xulu

et al.

Smart Materials in Medicine, Journal Year: 2023, Volume and Issue: 4, P. 639 - 647

Published: Jan. 1, 2023

Sepsis and sepsis-related organ dysfunction have been identified as significant global life-threatening health threats, with a high mortality rate despite ongoing research in the area. Timely diagnosis is essential such that treatment could be initiated early possible to ensure best outcome, since delayed intervention associated higher mortality. Patient stratification disease monitoring, present challenges sepsis management strategies, largely due heterogenicity of signs symptoms. Hence focus on potential biomarkers overcome these needed. Recently, extracellular vesicles (EVs), mainly exosome subtype, investigated regarding their role diagnostics, therapeutics drug delivery vehicles. Herein, we an up-to-date review covering circulating exosomes monitoring progression for sepsis. To provide context, pathophysiology highlighted. Future prospects, current recommendations are also identified.

Language: Английский

Citations

2

Exosome applications for the diagnosis and treatment of pancreatic ductal adenocarcinoma: An update (Review) DOI Creative Commons

Xinchi Luan,

Xuezhe Wang,

Gang Bian

et al.

Oncology Reports, Journal Year: 2024, Volume and Issue: 53(1)

Published: Nov. 20, 2024

Pancreatic ductal adenocarcinoma (PDAC) is a malignant neoplasm that typically manifests with subtle clinical manifestations in its early stages and frequently eludes diagnosis until the advanced phases of disease. The limited therapeutic options available for PDAC significantly contribute to high mortality rate, highlighting urgent need novel biomarkers capable effectively identifying facilitating precise diagnosis. pivotal role cellular exosomes both pathogenesis interventions has been underscored. Furthermore, researchers have acknowledged potential as targeted drug carriers against regulatory cells treating PDAC. present article aims provide comprehensive review encompassing recent advancements utilizing elucidating mechanisms underlying disease development, patterns metastasis, diagnostic techniques treatment strategies associated

Language: Английский

Citations

0